324 related articles for article (PubMed ID: 33804219)
1. Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression.
Caso VM; Manzo V; Pecchillo Cimmino T; Conti V; Caso P; Esposito G; Russo V; Filippelli A; Ammendola R; Cattaneo F
Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33804219
[TBL] [Abstract][Full Text] [Related]
2. Unleashing the power of formyl peptide receptor 2 in cardiovascular disease.
Prevete N; Poto R; Marone G; Varricchi G
Cytokine; 2023 Sep; 169():156298. PubMed ID: 37454543
[TBL] [Abstract][Full Text] [Related]
3. The Two Formyl Peptide Receptors Differently Regulate GPR84-Mediated Neutrophil NADPH Oxidase Activity.
Mårtensson J; Sundqvist M; Manandhar A; Ieremias L; Zhang L; Ulven T; Xie X; Björkman L; Forsman H
J Innate Immun; 2021; 13(4):242-256. PubMed ID: 33789297
[TBL] [Abstract][Full Text] [Related]
4. Pro-Resolving FPR2 Agonists Regulate NADPH Oxidase-Dependent Phosphorylation of HSP27, OSR1, and MARCKS and Activation of the Respective Upstream Kinases.
Ammendola R; Parisi M; Esposito G; Cattaneo F
Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33477989
[TBL] [Abstract][Full Text] [Related]
5. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT
Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772
[TBL] [Abstract][Full Text] [Related]
6. Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver.
Lee C; Han J; Jung Y
Exp Mol Med; 2023 Feb; 55(2):325-332. PubMed ID: 36750693
[TBL] [Abstract][Full Text] [Related]
7. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.
Ye RD; Boulay F; Wang JM; Dahlgren C; Gerard C; Parmentier M; Serhan CN; Murphy PM
Pharmacol Rev; 2009 Jun; 61(2):119-61. PubMed ID: 19498085
[TBL] [Abstract][Full Text] [Related]
8. Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling.
Zhang S; Gong H; Ge Y; Ye RD
Pharmacol Res; 2020 Nov; 161():105117. PubMed ID: 32768626
[TBL] [Abstract][Full Text] [Related]
9. Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.
Cattaneo F; Parisi M; Ammendola R
Int J Mol Sci; 2013 Apr; 14(4):7193-230. PubMed ID: 23549262
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2.
Zhuang Y; Wang L; Guo J; Sun D; Wang Y; Liu W; Xu HE; Zhang C
Nat Commun; 2022 Feb; 13(1):1054. PubMed ID: 35217703
[TBL] [Abstract][Full Text] [Related]
11. Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology.
Tylek K; Trojan E; Regulska M; Lacivita E; Leopoldo M; Basta-Kaim A
Pharmacol Rep; 2021 Aug; 73(4):1004-1019. PubMed ID: 34105114
[TBL] [Abstract][Full Text] [Related]
12. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
Kretschmer D; Rautenberg M; Linke D; Peschel A
J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
[TBL] [Abstract][Full Text] [Related]
13. 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.
Vergelli C; Schepetkin IA; Ciciani G; Cilibrizzi A; Crocetti L; Giovannoni MP; Guerrini G; Iacovone A; Kirpotina LN; Khlebnikov AI; Ye RD; Quinn MT
Bioorg Med Chem; 2016 Jun; 24(11):2530-2543. PubMed ID: 27134116
[TBL] [Abstract][Full Text] [Related]
14. Structural and conformational studies of biased agonism through formyl peptide receptors.
Liao Q; Ye RD
Am J Physiol Cell Physiol; 2022 May; 322(5):C939-C947. PubMed ID: 35385323
[TBL] [Abstract][Full Text] [Related]
15. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses.
Cooray SN; Gobbetti T; Montero-Melendez T; McArthur S; Thompson D; Clark AJ; Flower RJ; Perretti M
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18232-7. PubMed ID: 24108355
[TBL] [Abstract][Full Text] [Related]
16. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
17. Phosphoproteomic analysis sheds light on intracellular signaling cascades triggered by Formyl-Peptide Receptor 2.
Cattaneo F; Russo R; Castaldo M; Chambery A; Zollo C; Esposito G; Pedone PV; Ammendola R
Sci Rep; 2019 Nov; 9(1):17894. PubMed ID: 31784636
[TBL] [Abstract][Full Text] [Related]
18. Emerging contributions of formyl peptide receptors to neurodegenerative diseases.
Busch L; Vieten S; Brödel S; Endres K; Bufe B
Biol Chem; 2022 Jan; 403(1):27-41. PubMed ID: 34505459
[TBL] [Abstract][Full Text] [Related]
19. The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.
He HQ; Ye RD
Molecules; 2017 Mar; 22(3):. PubMed ID: 28335409
[TBL] [Abstract][Full Text] [Related]
20. Formyl peptide receptor 1 up-regulation and formyl peptide receptor 2/3 down-regulation of blood immune cells along with defective lipoxin A4/resolvin D1 production in obstructive sleep apnea patients.
Chen YC; Su MC; Chin CH; Lin IC; Hsu PY; Liou CW; Huang KT; Wang TY; Lin YY; Zheng YX; Hsiao CC; Lin MC
PLoS One; 2019; 14(5):e0216607. PubMed ID: 31116781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
